Home > Boards > US OTC > Delisted > Nuo Therapeutics Inc. (fka NUOTQ)

Cytomedix Licenses Technology Patent to Smith & Nephew

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Telephonics Member Profile
 
Followed By 3
Posts 1,303
Boards Moderated 1
Alias Born 04/02/03
160x600 placeholder
Four-Woman Group That Fought U.K. Algorithms Steps Up for Tech-Worker Rights
LONDON -- A four-woman technology-advocacy group that forced the British government to scrap a controversial algorithm for processing visas and led a public backlash over a tool for predicting high-school grades now is taking on Facebook Inc. and Uber Technologies Inc. over worker rights.
CEOs Can't Avoid Politics, Says Pernod Ricard Executive: 'We Are All in the Fray'
Zack Snyder's 'Army of the Dead' and Other Netflix Movies Turn Up in Theaters
Former Apple Engineer Accuses Company of Defamatory Statements Over Dismissal
Vivendi: Procedures for Obtaining or Consulting Information on the Combined General Shareholders' Meeting to be Held on June ...
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers -- 2nd Update
Top Company News of the Day
PNC Receives Regulatory Approval to Acquire BBVA USA
McDonald's, Tesla, Disney: Stocks That Defined the Week
Hertz Gets Court Approval for Bankruptcy Deal With Top Bidders -- Update
Correction to Amazon 75,000 Workers Article on May 13
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers -- Update
Top Stories of the Day
Walmart to Stop Requiring Masks for Vaccinated Workers and Shoppers
IPO Market Faces a Critical Juncture
Stocks Rebound but Suffer Weekly Losses
Hertz Gets Court Approval for Bankruptcy Deal With Top Bidders Knighthead and Certares
Why the CDC Told Fully Vaccinated Americans They Didn't Need to Wear Face Masks Anymore
Matt Gaetz Associate Joel Greenberg Set to Plead Guilty to Sex Trafficking
Bank of America Reaches Tentative $75 Million Settlement in Excessive Fees Case, Reuters Reports
Stock Gains Accelerate in Afternoon Trading
Telephonics   Tuesday, 10/23/07 11:52:13 AM
Re: None
Post # of 840 
Cytomedix Licenses Technology Patent to Smith & Nephew
Tuesday October 16, 2:00 pm ET


ROCKVILLE, Md., Oct. 16, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF - News) today announced that it has entered into a licensing agreement with Smith & Nephew, Inc., a global medical technology business, specializing in Orthopedic Trauma & Clinical Therapies, Orthopedic Reconstruction, Endoscopy and Advanced Wound Management products.
ADVERTISEMENT



Under the agreement Cytomedix has granted to Smith & Nephew a non-exclusive license under its key ``Knighton'' patent (U.S. Patent No. 5,165,938) for all applications of its autologous platelet releasate therapy except for use in the chronic wound market.

``We are very pleased to license our proprietary technology to an esteemed company such as Smith & Nephew for its own platelet gel products, while at the same time excluding rights to the chronic wound market, where Cytomedix is the only company with a Food and Drug Administration (FDA) cleared platelet gel therapy product with an indication for use on chronic wounds,'' said Dr. Kshitij Mohan, Ph.D., Cytomedix's Chairman and Chief Executive Officer. ``This agreement will provide us with additional cash and another expected royalty stream. As a result of our recently announced agreement with our patent counsel, we will not be required to pay any contingent legal fees from the proceeds received from Smith & Nephew as a result of this agreement. These agreements come at an opportune time as the Company prepares to launch its new AutoloGel(tm) System that was just cleared by the Food and Drug Administration.''

Cytomedix recently announced that it had obtained clearance from the FDA to market its AutoloGel System for use on a wide variety of wounds, including diabetic ulcers, leg ulcers and pressure ulcers. The Company has also recently announced progress in its efforts to obtain national Medicare coverage for platelet gel therapy.




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences